Hematologic malignancies are neoplasms that affect the blood, bone marrow, and lymph nodes. Hematological malignancies are the most common forms of leukemia, lymphoma, and myeloma, with numerous subtypes. The general symptoms of leukemia are fatigue, increased susceptibility to infection, bleeding, and the formation of bruises easily. Typical lymphoma symptoms are night sweats and involuntary weight loss, recurrent fever, fatigue, and itching. Myeloma patients often have bone pain, fatigue, anemia, hypercalcemia or infection symptoms. Adverse effects of hematologic malignancies and treatments cause abnormality in physical function and quality of life. Treatments such as chemotherapy, radiotherapy and hematopoietic stem cell transplantation, which may have side effects on the body systems are used in early or late period. The most common side effect due to chemotherapy is fatigue. Vomiting, weight loss, anemia, depression, decreased aerobic capacity, loss of muscle strength, decreased physical functioning and deterioration in the quality of life are indirect side effects seen in patients. In the literature, side effects of hematological malignancies have been investigated after treatment in patients. However, no study investigated exercise capacity, quality of life, physical activity level and pulmonary functions on newly diagnosed hematologic malignant patients. Therefore, the investigators aimed to compare aforementioned outcomes in newly diagnosed hematologic malignant patients and healthy controls.
According to sample size calculation 30 newly diagnosed hematologic malignant patients and 30 healthy individuals will be included. Before treatment submaximal exercise capacity, physical activity, quality of life, pulmonary functions, respiratory and peripheral muscle strength, respiratory muscle endurance, dyspnea and fatigue perception, anxiety and depression will be evaluated. Primary outcome measurements are exercise capacity, physical activity, quality of life, secondary outcomes are respiratory and peripheral muscle strength, respiratory muscle endurance, pulmonary functions, dyspnea and fatigue perception, anxiety and depression.
Study Type
OBSERVATIONAL
Enrollment
30
Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation
Yenimahalle, Turkey (Türkiye)
Functional exercise capacity
Evaluated using 6-minute walking test
Time frame: first day
Physical activity
Evaluated using a metabolic holter
Time frame: first day
General quality of life
Evaluated using QOL using European Organization for Research and Treatment of Cancer QOL Questionnaire (EORTCQOL)
Time frame: second day
Disease-specific quality of life
The Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu)
Time frame: second day
FACT
The Functional Assessment of Cancer Therapy-Anemia (FACT-An)
Time frame: second day
Pulmonary functions
Evaluated using spirometer
Time frame: first day
Muscle strength
Evaluated using hand-held dynamometer for peripheral muscles (shoulder abduction, shoulder flexion, knee extension, hand grip strength)
Time frame: second day
Respiratory muscle strength
Evaluated using mouth pressure device
Time frame: second day
Respiratory muscle endurance
Evaluated using respiratory muscle trainer (POWERbreathe)
Time frame: second day
Fatigue
Evaluated using Fatigue Severity Scale
Time frame: second day
Dyspnea
Evaluated using Modified Medical Research Council Dyspnea scale (MMRC)
Time frame: first day
Activity dyspnea
Evaluated using Modified Borg Scale
Time frame: first day
Anxiety
Evaluated using Hospital Anxiety and Depression Scale
Time frame: second day
Depression
Montgomery-Åsberg Depression Rating Scale
Time frame: second day
Hospital depression
Evaluated using Hospital Anxiety and Depression Scale
Time frame: second day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.